Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study von Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

Volltext

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MA... von Mohty, M, Tomasson, M, Arnulf, B, Bahlis, N, Prince, M, Niesvizky, R, Rodrgue-Otero, P, Martine-Lopez, J, Koehne, G, Jethava, Y, Gabayan, A, Stevens, D, Nooka, A, Raje, N, Iida, S, Leip, E, Conte, U, Czibere, A, Viqueira, A, Blunk, V, Lesokhin, A

Volltext

Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly admini... von Mohty, Mohamad, Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Prince, H. Miles, Niesvizky, Ruben, Rodríguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Jethava, Yogesh, Gabayan, A. Eli, Stevens, Don A., Nooka, Ajay K., Raje, Noopur S., Iida, Shinsuke, Leip, Eric, Conte, Umberto, Czibere, Akos Gabor, Viqueira, Andrea, Lesokhin, Alexander M.

Volltext

TRUST-II: A global phase II study for taletrectinib in ROS1 fusion–positive lung cancer and other solid tumors von Nagasaka, Misako, Sugawara, Shunichi, Choi, Chang-Min, Okamoto, Tatsuro, Yanagitani, Noriko, Nosaki, Kaname, Takahashi, Toshiaki, Fujiwara, Yutaka, Hayashi, Hidetoshi, Khoury, John, Nieva, Jorge J., Gabayan, A. Eli, Raez, Luis E., Chen, Hongbin, Dimou, Anastasios, Pennell, Nathan A., Liu, Geoffrey, Ou, Sai-Hong Ignatius, Seto, Takashi, Ohe, Yuichiro

Volltext

Global impact of COVID-19 on newborn screening programmes von Koracin, Vanesa, Loeber, J Gerard, Mlinaric, Matej, Battelino, Tadej, Bonham, James R, Groselj, Urh

Volltext

PROPEL: A phase 1/2 trial of NKTR-214 (CD122-biased agonist) combined with anti-PD-1 (pembrolizumab) or anti-PD-L1 (atezolizumab) in patients (pts) with advanced solid tumors von Vaena, Daniel A., Chaves, Jorge, Vogelzang, Nicholas J., Matrana, Marc Ryan, Gabayan, A. Eli, Riese, Matthew John, Cho, Daniel C., Tagliaferri, Mary Ann, Zalevsky, Jonathan, Xie, Sunny, Hoch, Ute, RIZWAN, AHSAN NAQI, Aung, Sandra, Imperiale, Michael, Schwarz, James K.

Volltext

Abdominal Tuberculosis in Patients Infected with the Human Immunodeficiency Virus von Fee, Martin J., Oo, Maung M., Gabayan, Afshin E., Radin, D. Randall, Barnes, Peter F.

Volltext

A phase 1b/2 study of INCB039110 + nab-paclitaxel (N) and gemcitabine (G) in patients (pts) with advanced solid tumors and pancreatic cancer (PC) von Beatty, Gregory Lawrence, Shahda, Safi, Beck, J. Thaddeus, Uppal, Nikhil Premparkash, Cohen, Steven J., Donehower, Ross C., Gabayan, A. Eli, Assad, Albert, Switzky, Julie C., Zhen, Huiling, Von Hoff, Daniel D.

Volltext

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results von Lesokhin, Alexander M., Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Miles Prince, H., Niesvizky, Ruben, Rodrίguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Touzeau, Cyrille, Jethava, Yogesh, Quach, Hang, Depaus, Julien, Yokoyama, Hisayuki, Gabayan, Afshin Eli, Stevens, Don A., Nooka, Ajay K., Manier, Salomon, Raje, Noopur, Iida, Shinsuke, Raab, Marc-Steffen, Searle, Emma, Leip, Eric, Sullivan, Sharon T., Conte, Umberto, Elmeliegy, Mohamed, Czibere, Akos, Viqueira, Andrea, Mohty, Mohamad

Volltext

Nonconcordance between Clinical and Head CT Findings: The Specter of Overdiagnosis von O'Laughlin, Kelli N., Hoffman, Jerome R., Go, Steven, Gabayan, Gelareh Z., Iqbal, Erum, Merchant, Guy, Lopez-Freeman, Roberto A., Zucker, Michael I., Mower, William R.

Volltext

GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas:A Retrospective Multi-institutional Analysis von Gabayan, Arash J., Green, Sylvan B., Sanan, Abhay, Jenrette, Joseph, Schultz, Christopher, Papagikos, Michael, Tatter, Stephen P., Patel, Ashish, Amin, Pradip, Lustig, Robert, Bastin, Kenneth T., Watson, Gordon, Burri, Stuart, Stea, Baldassarre

Volltext

252 Gliasite radiotherapy boost as part of initial treatment of malignant gliomas: A multi-institutional analysis von Welsh, J., Gabayan, A., Sanan, A., Green, S., Haas, M., Burris, S., Bishop, M., Stea, B.

Volltext

Thrombolytic therapy vs angioplasty in acute myocardial infarction von Yee, Aynna, Gabayan, Arash, Carbajal, Enrique V

Volltext

Gliasite radiotherapy system for treatment of recurrent malignant glioma: A multi-institutional analysis von GABAYAN, A, SANAN, A, BASTIN, K, BURRI, S, GREEN, S, JENRETTE, J, LUSTIG, R, PAPAGIKOS, M, PATEL, A, SCHULTZ, C

Volltext

Thrombolytic Therapy vs Angioplasty in Acute Myocardial Infarction von Pechlaner, Christoph, Bellmann, Romuald

Volltext

The effect of anterior cruciate ligament graft rotation on knee laxity and graft tension: An in vitro biomechanical analysis von HAME, Sharon L, MARKOLF, Keith L, GABAYAN, Arash J, HUNTER, D. Monte, DAVIS, Brent, SHAPIRO, Matthew S

Volltext

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin von Nemeth, Elizabeta, Rivera, Seth, Gabayan, Victoria, Keller, Charlotte, Taudorf, Sarah, Pedersen, Bente K, Ganz, Tomas

Volltext

Hepcidin-Induced Hypoferremia Is a Critical Host Defense Mechanism against the Siderophilic Bacterium Vibrio vulnificus von Arezes, João, Jung, Grace, Gabayan, Victoria, Valore, Erika, Ruchala, Piotr, Gulig, Paul A., Ganz, Tomas, Nemeth, Elizabeta, Bulut, Yonca

Volltext

Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia von Kautz, Léon, Jung, Grace, Du, Xin, Gabayan, Victoria, Chapman, Justin, Nasoff, Marc, Nemeth, Elizabeta, Ganz, Tomas

Volltext

Suppression of hepcidin during anemia requires erythropoietic activity von Pak, Mihwa, Lopez, Miguel A., Gabayan, Victroia, Ganz, Tomas, Rivera, Seth

Volltext